Class III · Low riskTerminated Initiated Apr 23, 2012 (14 years ago)
Jolessa (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, each Dispenser…
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets.
What was recalled
Jolessa (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, each Dispenser contains 91 tablets, 91 Day Regimen, Rx Only, Shaping Women's Health, Manufactured by: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-9123-66.
Recalling firm
Teva Pharmaceuticals USA, Inc.
NDC code
0555-9123-66
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1384-2012
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.